JAMA republishes an article from The Medical Letter on Drugs and Therapeutics

Announcement Date: January 1, 2015

Concludes “Chemoprophylaxis with antiviral drugs is not recommended for healthy persons exposed to influenza. A neuraminidase inhibitor, either oseltamivir (Tamiflu) or zanamivir (Relenza), remains the drug of choice for treatment of patients with influenza. Oseltamivir is preferred for use in pregnant women and in patients with underlying airway disease.” Evidence from the the Cochrane review is not cited.

From The Medical Letter on Drugs and Therapeutics. Antiviral Drugs for Seasonal Influenza 2014-2015. JAMA 2015; 313(4): 41314.

Explore the CEBM